Discovery of inhibitors of the novel oncology target, Pin 1: A case study in structure guided fragment evolution

被引：0

作者：

Ray, Stuart C. ^{[1
]}

Baker, Lisa ^{[2
]}

Davis, Ben ^{[2
]}

Fromont, Christophe ^{[1
]}

Matassova, Natalia ^{[2
]}

Moore, Jon ^{[3
]}

Murray, James ^{[2
]}

Nunns, Claire ^{[1
]}

Potter, Andrew ^{[1
]}

Richardson, Christine ^{[4
]}

Robertson, Alan ^{[2
]}

Robinson, David ^{[2
]}

Simmonite, Heather ^{[2
]}

Surgenor, Allan ^{[2
]}

机构：

[1] Vernalis, Chem, Cambridge CB21 6GB, England

[2] Vernalis, Struct Sci, Cambridge CB21 6GB, England

[3] Vernalis, Oncol, Cambridge CB21 6GB, England

[4] Vernalis, Computat Chem, Cambridge CB21 6GB, England

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

61-MEDI

引用

页数：1

共 50 条

[41] Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2
Liu, Qiufeng
Huang, Fubao
Yuan, Xiaojing
Wang, Kai
Zou, Yi
Shen, Jianhua
Xu, Yechun
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (24) : 10231 - 10244
[42] Identifying novel JAK1 inhibitors by structure-based virtual screening: A case study of using drug discovery tools at mcule.com
Kiss, Robert
Szalai, Ferenc
Sayeski, Peter P.
Keseru, Gyoergy M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[43] Design and synthesis of indolylpyridone derivatives for use as CHK1 inhibitors: A case study in structure based drug discovery
Fiumana, Andrea
Bedford, Simon
Borgognoni, Jenifer
Drysdale, Martin
Foloppe, Nicolas
Jordan, Allan M.
Massey, Andrew
Stokes, Stephen
Web, Paul
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
[44] Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening
Giordanetto, Fabrizio
Kull, Bengt
Dellsen, Anita
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 829 - 835
[45] Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors
Shuai, Wen
Xiao, Huan
Yang, Panpan
Zhang, Yiwen
Bu, Faqian
Wu, Yongya
Sun, Qiu
Wang, Guan
Ouyang, Liang
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6425 - 6455
[46] Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement
Li, Xiao
Gao, Ping
Huang, Boshi
Zhou, Zhongxia
Yu, Zhao
Yuan, Zheng
Liu, Huiqing
Pannecouque, Christophe
Daelemans, Dirk
De Clercq, Erik
Zhan, Peng
Liu, Xinyong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 : 190 - 201
[47] Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening
Ge, Huizhen
Peng, Lizeng
Sun, Zhou
Liu, Huanxiang
Shen, Yulin
Yao, Xiaojun
FRONTIERS IN PHARMACOLOGY, 2022, 13
[48] Structure-based virtual screening towards the discovery of novel FOXM1 inhibitors
Xie, Zhuo-Song
Zhou, Zi-Ying
Sun, Lian-Qi
Yi, Hong
Xue, Si-Tu
Li, Zhuo-Rong
FUTURE MEDICINAL CHEMISTRY, 2022, 14 (04) : 207 - 219
[49] Structure-guided Development of Novel Benzothiophene Derivatives as PLK1-PBD Inhibitors
Huang, Daowei
Zhang, Jing
Yang, Xiaocong
Tan, Xiangduan
Chai, Tingting
Ma, Lindeng
Zhao, Bingyang
Chen, Ying
Yang, Jixia
Zhang, Yue
LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (11) : 2163 - 2174
[50] Comparative omics analysis for novel target discovery in plant pathogens: A case study for Magnaporthe oryzae
Luthfi, Muhammad
Piapukiew, Jittra
Pandey, Ras B.
Sompornpisut, Pornthep
PLANT PATHOLOGY, 2024, 73 (03) : 564 - 577

← 1 2 3 4 5 →